James Sailer, MPP

James Sailer is executive director of the Population Council’s Center for Biomedical Research (CBR), which conducts research and develops new methods of contraception, HIV prevention, and STI prevention. Sailer provides strategic direction to the Council’s product development program, and supervises a staff of scientists, fellows, and operations professionals at CBR’s laboratories on the campus of Rockefeller University.

Sailer led the team that received FDA approval for Annovera®, a one-year contraceptive vaginal system that is the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control.